1 Introduction to Research & Analysis Reports
1.1 Compounding Chemotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Compounding Chemotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Compounding Chemotherapy Overall Market Size
2.1 Global Compounding Chemotherapy Market Size: 2022 VS 2029
2.2 Global Compounding Chemotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Compounding Chemotherapy Players in Global Market
3.2 Top Global Compounding Chemotherapy Companies Ranked by Revenue
3.3 Global Compounding Chemotherapy Revenue by Companies
3.4 Top 3 and Top 5 Compounding Chemotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Compounding Chemotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Compounding Chemotherapy Players in Global Market
3.6.1 List of Global Tier 1 Compounding Chemotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Compounding Chemotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Compounding Chemotherapy Market Size Markets, 2022 & 2029
4.1.2 Gravimetric Automated Compounding Device (Weight-Based)
4.1.3 Volumetric Automated Compounding Device (Volume-Based)
4.2 By Type – Global Compounding Chemotherapy Revenue & Forecasts
4.2.1 By Type – Global Compounding Chemotherapy Revenue, 2018-2023
4.2.2 By Type – Global Compounding Chemotherapy Revenue, 2024-2029
4.2.3 By Type – Global Compounding Chemotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Compounding Chemotherapy Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Blood Cancer
5.1.4 Prostate Cancer
5.1.5 Gastrointestinal Cancer
5.1.6 Respiratory/Lung Cancer
5.1.7 Others
5.2 By Application – Global Compounding Chemotherapy Revenue & Forecasts
5.2.1 By Application – Global Compounding Chemotherapy Revenue, 2018-2023
5.2.2 By Application – Global Compounding Chemotherapy Revenue, 2024-2029
5.2.3 By Application – Global Compounding Chemotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Compounding Chemotherapy Market Size, 2022 & 2029
6.2 By Region – Global Compounding Chemotherapy Revenue & Forecasts
6.2.1 By Region – Global Compounding Chemotherapy Revenue, 2018-2023
6.2.2 By Region – Global Compounding Chemotherapy Revenue, 2024-2029
6.2.3 By Region – Global Compounding Chemotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Compounding Chemotherapy Revenue, 2018-2029
6.3.2 US Compounding Chemotherapy Market Size, 2018-2029
6.3.3 Canada Compounding Chemotherapy Market Size, 2018-2029
6.3.4 Mexico Compounding Chemotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Compounding Chemotherapy Revenue, 2018-2029
6.4.2 Germany Compounding Chemotherapy Market Size, 2018-2029
6.4.3 France Compounding Chemotherapy Market Size, 2018-2029
6.4.4 U.K. Compounding Chemotherapy Market Size, 2018-2029
6.4.5 Italy Compounding Chemotherapy Market Size, 2018-2029
6.4.6 Russia Compounding Chemotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Compounding Chemotherapy Market Size, 2018-2029
6.4.8 Benelux Compounding Chemotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Compounding Chemotherapy Revenue, 2018-2029
6.5.2 China Compounding Chemotherapy Market Size, 2018-2029
6.5.3 Japan Compounding Chemotherapy Market Size, 2018-2029
6.5.4 South Korea Compounding Chemotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Compounding Chemotherapy Market Size, 2018-2029
6.5.6 India Compounding Chemotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Compounding Chemotherapy Revenue, 2018-2029
6.6.2 Brazil Compounding Chemotherapy Market Size, 2018-2029
6.6.3 Argentina Compounding Chemotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Compounding Chemotherapy Revenue, 2018-2029
6.7.2 Turkey Compounding Chemotherapy Market Size, 2018-2029
6.7.3 Israel Compounding Chemotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Compounding Chemotherapy Market Size, 2018-2029
6.7.5 UAE Compounding Chemotherapy Market Size, 2018-2029
7 Compounding Chemotherapy Companies Profiles
7.1 Braun Melsungen AG
7.1.1 Braun Melsungen AG Company Summary
7.1.2 Braun Melsungen AG Business Overview
7.1.3 Braun Melsungen AG Compounding Chemotherapy Major Product Offerings
7.1.4 Braun Melsungen AG Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.1.5 Braun Melsungen AG Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Compounding Chemotherapy Major Product Offerings
7.2.4 Pfizer Inc. Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Baxter
7.3.1 Baxter Company Summary
7.3.2 Baxter Business Overview
7.3.3 Baxter Compounding Chemotherapy Major Product Offerings
7.3.4 Baxter Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.3.5 Baxter Key News & Latest Developments
7.4 Grifols SA
7.4.1 Grifols SA Company Summary
7.4.2 Grifols SA Business Overview
7.4.3 Grifols SA Compounding Chemotherapy Major Product Offerings
7.4.4 Grifols SA Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.4.5 Grifols SA Key News & Latest Developments
7.5 The Metrix Company
7.5.1 The Metrix Company Company Summary
7.5.2 The Metrix Company Business Overview
7.5.3 The Metrix Company Compounding Chemotherapy Major Product Offerings
7.5.4 The Metrix Company Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.5.5 The Metrix Company Key News & Latest Developments
7.6 Added Pharma
7.6.1 Added Pharma Company Summary
7.6.2 Added Pharma Business Overview
7.6.3 Added Pharma Compounding Chemotherapy Major Product Offerings
7.6.4 Added Pharma Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.6.5 Added Pharma Key News & Latest Developments
7.7 Equashield
7.7.1 Equashield Company Summary
7.7.2 Equashield Business Overview
7.7.3 Equashield Compounding Chemotherapy Major Product Offerings
7.7.4 Equashield Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.7.5 Equashield Key News & Latest Developments
7.8 Millers Pharmacy
7.8.1 Millers Pharmacy Company Summary
7.8.2 Millers Pharmacy Business Overview
7.8.3 Millers Pharmacy Compounding Chemotherapy Major Product Offerings
7.8.4 Millers Pharmacy Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.8.5 Millers Pharmacy Key News & Latest Developments
7.9 Comecer S.P.A.
7.9.1 Comecer S.P.A. Company Summary
7.9.2 Comecer S.P.A. Business Overview
7.9.3 Comecer S.P.A. Compounding Chemotherapy Major Product Offerings
7.9.4 Comecer S.P.A. Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.9.5 Comecer S.P.A. Key News & Latest Developments
7.10 Omnicell
7.10.1 Omnicell Company Summary
7.10.2 Omnicell Business Overview
7.10.3 Omnicell Compounding Chemotherapy Major Product Offerings
7.10.4 Omnicell Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.10.5 Omnicell Key News & Latest Developments
7.11 Icon group
7.11.1 Icon group Company Summary
7.11.2 Icon group Business Overview
7.11.3 Icon group Compounding Chemotherapy Major Product Offerings
7.11.4 Icon group Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.11.5 Icon group Key News & Latest Developments
7.12 Dedalus Group
7.12.1 Dedalus Group Company Summary
7.12.2 Dedalus Group Business Overview
7.12.3 Dedalus Group Compounding Chemotherapy Major Product Offerings
7.12.4 Dedalus Group Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.12.5 Dedalus Group Key News & Latest Developments
7.13 Arxium
7.13.1 Arxium Company Summary
7.13.2 Arxium Business Overview
7.13.3 Arxium Compounding Chemotherapy Major Product Offerings
7.13.4 Arxium Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.13.5 Arxium Key News & Latest Developments
7.14 Sterline S.R.L.
7.14.1 Sterline S.R.L. Company Summary
7.14.2 Sterline S.R.L. Business Overview
7.14.3 Sterline S.R.L. Compounding Chemotherapy Major Product Offerings
7.14.4 Sterline S.R.L. Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.14.5 Sterline S.R.L. Key News & Latest Developments
7.15 Loccioni
7.15.1 Loccioni Company Summary
7.15.2 Loccioni Business Overview
7.15.3 Loccioni Compounding Chemotherapy Major Product Offerings
7.15.4 Loccioni Compounding Chemotherapy Revenue in Global Market (2018-2023)
7.15.5 Loccioni Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Compounding Chemotherapy Market Opportunities & Trends in Global Market
Table 2. Compounding Chemotherapy Market Drivers in Global Market
Table 3. Compounding Chemotherapy Market Restraints in Global Market
Table 4. Key Players of Compounding Chemotherapy in Global Market
Table 5. Top Compounding Chemotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Compounding Chemotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Compounding Chemotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Compounding Chemotherapy Product Type
Table 9. List of Global Tier 1 Compounding Chemotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Compounding Chemotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Compounding Chemotherapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Compounding Chemotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Compounding Chemotherapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Compounding Chemotherapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Compounding Chemotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Compounding Chemotherapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Compounding Chemotherapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Compounding Chemotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Compounding Chemotherapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Compounding Chemotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Compounding Chemotherapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Compounding Chemotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Compounding Chemotherapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Compounding Chemotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Compounding Chemotherapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Compounding Chemotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Compounding Chemotherapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Compounding Chemotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Compounding Chemotherapy Revenue, (US$, Mn), 2024-2029
Table 30. Braun Melsungen AG Company Summary
Table 31. Braun Melsungen AG Compounding Chemotherapy Product Offerings
Table 32. Braun Melsungen AG Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Braun Melsungen AG Key News & Latest Developments
Table 34. Pfizer Inc. Company Summary
Table 35. Pfizer Inc. Compounding Chemotherapy Product Offerings
Table 36. Pfizer Inc. Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Inc. Key News & Latest Developments
Table 38. Baxter Company Summary
Table 39. Baxter Compounding Chemotherapy Product Offerings
Table 40. Baxter Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. Baxter Key News & Latest Developments
Table 42. Grifols SA Company Summary
Table 43. Grifols SA Compounding Chemotherapy Product Offerings
Table 44. Grifols SA Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. Grifols SA Key News & Latest Developments
Table 46. The Metrix Company Company Summary
Table 47. The Metrix Company Compounding Chemotherapy Product Offerings
Table 48. The Metrix Company Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. The Metrix Company Key News & Latest Developments
Table 50. Added Pharma Company Summary
Table 51. Added Pharma Compounding Chemotherapy Product Offerings
Table 52. Added Pharma Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 53. Added Pharma Key News & Latest Developments
Table 54. Equashield Company Summary
Table 55. Equashield Compounding Chemotherapy Product Offerings
Table 56. Equashield Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 57. Equashield Key News & Latest Developments
Table 58. Millers Pharmacy Company Summary
Table 59. Millers Pharmacy Compounding Chemotherapy Product Offerings
Table 60. Millers Pharmacy Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 61. Millers Pharmacy Key News & Latest Developments
Table 62. Comecer S.P.A. Company Summary
Table 63. Comecer S.P.A. Compounding Chemotherapy Product Offerings
Table 64. Comecer S.P.A. Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 65. Comecer S.P.A. Key News & Latest Developments
Table 66. Omnicell Company Summary
Table 67. Omnicell Compounding Chemotherapy Product Offerings
Table 68. Omnicell Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 69. Omnicell Key News & Latest Developments
Table 70. Icon group Company Summary
Table 71. Icon group Compounding Chemotherapy Product Offerings
Table 72. Icon group Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 73. Icon group Key News & Latest Developments
Table 74. Dedalus Group Company Summary
Table 75. Dedalus Group Compounding Chemotherapy Product Offerings
Table 76. Dedalus Group Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 77. Dedalus Group Key News & Latest Developments
Table 78. Arxium Company Summary
Table 79. Arxium Compounding Chemotherapy Product Offerings
Table 80. Arxium Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 81. Arxium Key News & Latest Developments
Table 82. Sterline S.R.L. Company Summary
Table 83. Sterline S.R.L. Compounding Chemotherapy Product Offerings
Table 84. Sterline S.R.L. Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 85. Sterline S.R.L. Key News & Latest Developments
Table 86. Loccioni Company Summary
Table 87. Loccioni Compounding Chemotherapy Product Offerings
Table 88. Loccioni Compounding Chemotherapy Revenue (US$, Mn) & (2018-2023)
Table 89. Loccioni Key News & Latest Developments
List of Figures
Figure 1. Compounding Chemotherapy Segment by Type in 2022
Figure 2. Compounding Chemotherapy Segment by Application in 2022
Figure 3. Global Compounding Chemotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Compounding Chemotherapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Compounding Chemotherapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Compounding Chemotherapy Revenue in 2022
Figure 8. By Type - Global Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Compounding Chemotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Compounding Chemotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 16. US Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 20. Germany Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 28. China Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 34. Brazil Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Compounding Chemotherapy Revenue Market Share, 2018-2029
Figure 37. Turkey Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Compounding Chemotherapy Revenue, (US$, Mn), 2018-2029
Figure 41. Braun Melsungen AG Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Inc. Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Baxter Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Grifols SA Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. The Metrix Company Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Added Pharma Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Equashield Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Millers Pharmacy Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Comecer S.P.A. Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Omnicell Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Icon group Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Dedalus Group Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Arxium Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sterline S.R.L. Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Loccioni Compounding Chemotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
